Why GRAL? GRAIL, Inc. Analysis, Price & AI Insights | Whystock
GRAL
$62.75+8.35 (+15.35%)
After Hours$62.45-0.30 (-0.48%)· Last close May 6
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.